Add BrightSurf on Google Email

Elucidating the attributes of individuals with dyslipidemia identified during health checkups who do not visit medical institutions

A study analyzed health checkup data and found that individuals with mild dyslipidemia were less likely to seek medical follow-up compared to those with severe abnormalities. Nearly 80% of respondents did not follow up with a physician, highlighting the need for improved follow-up attendance at medical consultations.

SourceUniversity of Tsukuba·JournalJMA Journal·DateOct 25, 2024

Study finds minorities more likely to have ‘free’ preventive healthcare denied by insurers

A new study published in JAMA Network Open found that racial and ethnic minorities are more likely to have claims for free preventive care denied by insurance plans, leading to unexpected bills or lack of access. Healthcare providers also charge disadvantaged groups a higher amount for preventive services.

SourceUniversity of Massachusetts Amherst·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 3, 2024

Progression of subclinical atherosclerosis predicts all-cause mortality risk

A study published in JACC demonstrates that subclinical atherosclerosis burden and progression independently predict death from any cause. Asymptomatic individuals with high carotid plaque burden and coronary artery calcification are at increased risk of mortality.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateSep 30, 2024

ECU medical researchers confirm genetic link between Alzheimer’s and heart disease

Researchers at Edith Cowan University have uncovered a significant genetic connection between Alzheimer's disease and several coronary artery disease-related disorders, offering opportunities to improve health outcomes. The study found that some of the same genes played a role in or are associated across these conditions.

SourceEdith Cowan University·JournalInternational Journal of Molecular Sciences·TypeMeta-analysis·DateAug 15, 2024

Ketogenic Diet reduces friendly gut bacteria and raises cholesterol levels - University of Bath study

A new study published in Cell Reports Medicine found that a ketogenic diet can reduce beneficial gut bacteria and increase unfavorable fats in the blood. The diet, which is high in fat and low in carbohydrates, may have long-term health implications such as increased risk of heart disease and stroke.

SourceUniversity of Bath·JournalCell Reports Medicine·TypeRandomized controlled/clinical trial·DateAug 6, 2024

Study finds refined corn flour with added corn bran can lower cholesterol

A randomized crossover clinical trial reveals that swapping refined corn flour for a blend of refined corn flour and corn bran lowers LDL cholesterol concentrations by 5-13.3%. The study found significant reductions in LDL cholesterol among 70% of participants who consumed the blend, while whole-grain corn meal had no impact.

SourceWild Hive·JournalJournal of Nutrition·TypeRandomized controlled/clinical trial·DateAug 6, 2024

At risk of high cholesterol? Taking fish oil may help

A new study found that taking fish oil supplements can lower blood lipid levels in individuals with a genetic predisposition to high cholesterol. The research used genetic data from over 441,000 participants and found that fish oil supplementation can counteract the genetic risk of developing high cholesterol.

SourceUniversity of Georgia·JournalAmerican Journal of Clinical Nutrition·DateAug 5, 2024

The Lancet: Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two new risks—high cholesterol and vision loss

The Lancet Commission on dementia prevention recommends addressing 14 modifiable risk factors to prevent or delay nearly half of dementia cases. The report identifies two new risks: high LDL cholesterol and vision loss, which are associated with 9% of all dementia cases.

SourceThe Lancet·JournalThe Lancet·TypeLiterature review·DateJul 31, 2024

Older adults want to cut back on medication, but study shows need for caution

A new University of Michigan study found that over 82% of Americans aged 50-80 take one or more prescription medications, with 80% open to stopping certain drugs. However, researchers stress the importance of personalized guidance for deprescribing older adults, particularly those taking medication for cardiovascular disease or diabetes.

SourceMichigan Medicine - University of Michigan·JournalJournal of General Internal Medicine·TypeSurvey·DateJul 24, 2024

Adding genetic information to health checks improves identification of people at risk of heart attacks and strokes

Researchers have discovered a better way to identify those at high risk of potential heart attacks and strokes by adding genetic information to health checks. The study found that combining clinical risk scores with polygenic risk scores significantly improves identification rates, especially among younger people.

SourceUniversity of Leicester·JournalEuropean Heart Journal·TypeData/statistical analysis·DateJun 11, 2024

RNA inhibitor is shown safe and effective in reducing a wide range of cholesterol and triglyceride levels in the blood in Mount Sinai-led clinical trial

A clinical trial led by Mount Sinai researchers shows zodasiran, an RNA inhibitor targeting ANGPTL3, significantly reduces various types of cholesterol and triglycerides. The therapy also lowers apolipoprotein B, a lipid-transporting protein linked to heart disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 29, 2024

Can triglycerides-HDL-C ratio, HOMA-IR, ApoB, non-HDL cholesterol, and free cholesterol be laboratory-associated flags of female coronary atherosclerosis regardless of being diabetic?

Research finds insulin levels correlate with triglycerides, ApoB, non-HDL cholesterol, and free cholesterol in women with atherosclerotic coronary disease. The study suggests these laboratory-associated flags indicate early coronary atherosclerosis in both diabetic and non-diabetic women.

SourceBentham Science Publishers·JournalThe Open Biomarkers Journal·DateMay 24, 2024

New insights into cholesterol dynamics shed light on neurodegenerative disease

A study published in PNAS reveals the structure of a protein linked to neurodegenerative disease Niemann-Pick type C, which accumulates cholesterol within cellular compartments. The research sheds light on the complex mechanism of cholesterol distribution and its role in maintaining optimal levels.

SourceAarhus University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 3, 2024

Want to cut US heart risks? Get more people into primary care, study suggests

A new study suggests that most essential care for cardiovascular health happens in general primary care clinics, but many at high risk don't receive it. The study found that large percentages of people with major cardiovascular risk factors didn't see a primary care provider or cardiologist in the past year.

SourceMichigan Medicine - University of Michigan·JournalCirculation Cardiovascular Quality and Outcomes·TypeData/statistical analysis·DateApr 2, 2024

Clear shift in arterial diseases in diabetes

Studies at the University of Gothenburg found a clear shift in arterial disease risks in diabetes, with decreases in central organ diseases like heart attack and stroke, but increases in peripheral vessel complications. Closer monitoring of long-term blood sugar levels can reduce peripheral arterial disease risk by 30-50%.

SourceUniversity of Gothenburg·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateMar 28, 2024

More than half of American Indian youth may have abnormal or high cholesterol

A study funded by the National Institutes of Health found that more than 70% of American Indian young adults aged 20-39 and 50% of teens have abnormal or high cholesterol. High LDL cholesterol was linked to plaque buildup and cardiovascular events, emphasizing the need for early screenings and culturally relevant education.

SourceNIH/National Heart, Lung and Blood Institute·JournalJournal of the American Heart Association·DateMar 6, 2024

Outsmarting chemo-resistant ovarian cancer

Researchers have discovered a new way to target chemotherapy-resistant ovarian cancer cells by depriving them of cholesterol, leading to significant tumor growth reduction. The nanoparticles starve the cells of cholesterol, triggering cell death through oxidation of lipids in the cell membrane.

SourceNorthwestern University·JournalAdvanced Science·TypeExperimental study·DateFeb 21, 2024

Common hair loss and prostate drug may also cut heart disease risk in men and mice

A new study suggests that finasteride, a common hair loss and prostate drug, may also lower cholesterol levels and reduce cardiovascular disease risk in men. In mice, the researchers found significant correlations between finasteride use and lower cholesterol levels, as well as reduced inflammation and atherosclerosis progression.

Access to prescribed PCSK9 inhibitors remains a significant barrier leaving patients at risk for heart attacks and strokes

A new study reveals that utilization of PCSK9 inhibitors is low among high-risk patients, despite extensive evidence documenting their role in LDL-C reduction and the prevention of heart attacks. The study found that insurance coverage rejection or abandonment leads to significantly more cardiovascular events within 12 months.

SourceFamily Heart Foundation·JournalCirculation Cardiovascular Quality and Outcomes·TypeData/statistical analysis·DateFeb 20, 2024

Singapore scientists uncover a crucial link between cholesterol synthesis and cancer progression

Researchers at Duke-NUS Medical School discovered a novel enzyme, FAXDC2, that plays a pivotal role in cholesterol synthesis and cancer progression. The study highlights the potential vulnerability of cancer cells to targeted therapeutic intervention. Further research is needed to explore the therapeutic potential of targeting FAXDC2 i...

SourceDuke-NUS Medical School·JournalJournal of Clinical Investigation·TypeExperimental study·DateFeb 2, 2024